{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:16:12Z","timestamp":1783577772407,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T00:00:00Z","timestamp":1698537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T00:00:00Z","timestamp":1698537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012688","name":"Universit\u00e4t Rostock","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012688","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neuronal ceroid lipofuscinosis 6 (CLN6) is a rare and fatal autosomal recessive disease primarily affecting the nervous system in children. It is caused by a pathogenic mutation in the <jats:italic>CLN6<\/jats:italic> gene for which no therapy is available. Employing an untargeted metabolomics approach, we analyzed the metabolic changes in CLN6 subjects to see if this system could potentially yield biomarkers for diagnosis and monitoring disease progression. Neuronal-like cells were derived from human fibroblast lines from CLN6-affected subjects (n\u2009=\u20093) and controls (wild type, n\u2009=\u20093). These were used to assess the potential of a neuronal-like cell-based metabolomics approach to identify CLN6 distinctive and specific biomarkers. The most impacted metabolic profile is associated with sphingolipids, glycerophospholipids metabolism, and calcium signaling. Over 2700 spectral features were screened, and fifteen metabolites were identified that differed significantly between both groups, including the sphingolipids C16 GlcCer, C24 GlcCer, C24:1 GlcCer and glycerophospholipids PG 40:6 and PG 40:7. Of note, these fifteen metabolites were downregulated in the CLN6 disease group. This study is the first to analyze the metabolome of neuronal-like cells with a pathogenic mutation in the <jats:italic>CLN6<\/jats:italic> gene and to provide insights into their metabolomic alterations. This could allow for the development of novel biomarkers for monitoring CLN6 disease.<\/jats:p>","DOI":"10.1038\/s41598-023-45789-7","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:01:27Z","timestamp":1698577287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neuronal progenitor cells-based metabolomics study reveals dysregulated lipid metabolism and identifies putative biomarkers for CLN6 disease"],"prefix":"10.1038","volume":"13","author":[{"given":"Corina-Marcela","family":"Rus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Polla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Di Bucchianico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Hartkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunus","family":"Alpagu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cozma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,29]]},"reference":[{"key":"45789_CR1","volume-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"S Mole","year":"2011","unstructured":"Mole, S., Williams, R. & Goebel, H. The Neuronal Ceroid Lipofuscinoses (Batten Disease) (Oxford University Press, 2011)."},{"key":"45789_CR2","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.bbadis.2012.08.012","volume":"1795\u20131800","author":"M Haltia","year":"1832","unstructured":"Haltia, M. & Goebel, H. H. The neuronal ceroid-lipofuscinoses: A historical introduction. Biochim. Biophys. Acta 1795\u20131800, 2013. https:\/\/doi.org\/10.1016\/j.bbadis.2012.08.012 (1832).","journal-title":"Biochim. Biophys. Acta"},{"key":"45789_CR3","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.bbadis.2013.05.014","volume":"1832","author":"DN Palmer","year":"2013","unstructured":"Palmer, D. N., Barry, L. A., Tyynela, J. & Cooper, J. D. NCL disease mechanisms. Biochim. Biophys. Acta 1832, 1882\u20131893. https:\/\/doi.org\/10.1016\/j.bbadis.2013.05.014 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"45789_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1750-1172-8-19","volume":"8","author":"FM Santorelli","year":"2013","unstructured":"Santorelli, F. M. et al. Molecular epidemiology of childhood neuronal ceroid-lipofuscinosis in Italy. Orphanet. J. Rare Dis. 8, 19. https:\/\/doi.org\/10.1186\/1750-1172-8-19 (2013).","journal-title":"Orphanet. J. Rare Dis."},{"key":"45789_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.gene.2016.08.031","volume":"593","author":"DE Sleat","year":"2016","unstructured":"Sleat, D. E., Gedvilaite, E., Zhang, Y., Lobel, P. & Xing, J. Analysis of large-scale whole exome sequencing data to determine the prevalence of genetically-distinct forms of neuronal ceroid lipofuscinosis. Gene 593, 284\u2013291. https:\/\/doi.org\/10.1016\/j.gene.2016.08.031 (2016).","journal-title":"Gene"},{"key":"45789_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1212\/WNL.0b013e31825f0547","volume":"79","author":"RE Williams","year":"2012","unstructured":"Williams, R. E. & Mole, S. E. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology 79, 183\u2013191. https:\/\/doi.org\/10.1212\/WNL.0b013e31825f0547 (2012).","journal-title":"Neurology"},{"key":"45789_CR7","doi-asserted-by":"publisher","first-page":"165571","DOI":"10.1016\/j.bbadis.2019.165571","volume":"1866","author":"ES Butz","year":"2020","unstructured":"Butz, E. S., Chandrachud, U., Mole, S. E. & Cotman, S. L. Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses. Biochim. Biophys. Acta. Mol. Basis Dis. 1866, 165571. https:\/\/doi.org\/10.1016\/j.bbadis.2019.165571 (2020).","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"45789_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1086\/338708","volume":"70","author":"RB Wheeler","year":"2002","unstructured":"Wheeler, R. B. et al. The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane protein. Am. J. Hum. Genet. 70, 537\u2013542. https:\/\/doi.org\/10.1086\/338708 (2002).","journal-title":"Am. J. Hum. Genet."},{"key":"45789_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.yexcr.2004.04.042","volume":"298","author":"SE Mole","year":"2004","unstructured":"Mole, S. E. et al. CLN6, which is associated with a lysosomal storage disease, is an endoplasmic reticulum protein. Exp. Cell Res. 298, 399\u2013406. https:\/\/doi.org\/10.1016\/j.yexcr.2004.04.042 (2004).","journal-title":"Exp. Cell Res."},{"key":"45789_CR10","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.bbadis.2013.04.008","volume":"1801\u20131806","author":"A Schulz","year":"1832","unstructured":"Schulz, A., Kohlschutter, A., Mink, J., Simonati, A. & Williams, R. NCL diseases\u2014Clinical perspectives. Biochim. Biophys. Acta 1801\u20131806, 2013. https:\/\/doi.org\/10.1016\/j.bbadis.2013.04.008 (1832).","journal-title":"Biochim. Biophys. Acta"},{"key":"45789_CR11","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/dmcn.14346","volume":"62","author":"B Dozieres-Puyravel","year":"2020","unstructured":"Dozieres-Puyravel, B. et al. Paediatric-onset neuronal ceroid lipofuscinosis: First symptoms and presentation at diagnosis. Dev. Med. Child Neurol. 62, 528\u2013530. https:\/\/doi.org\/10.1111\/dmcn.14346 (2020).","journal-title":"Dev. Med. Child Neurol."},{"key":"45789_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/21678707.2019.1684258","volume":"7","author":"JB Rosenberg","year":"2019","unstructured":"Rosenberg, J. B., Chen, A., Kaminsky, S. M., Crystal, R. G. & Sondhi, D. Advances in the treatment of neuronal ceroid lipofuscinosis. Expert Opin. Orphan Drugs 7, 473\u2013500. https:\/\/doi.org\/10.1080\/21678707.2019.1684258 (2019).","journal-title":"Expert Opin. Orphan Drugs"},{"key":"45789_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41582-019-0138-8","volume":"15","author":"TB Johnson","year":"2019","unstructured":"Johnson, T. B. et al. Therapeutic landscape for Batten disease: Current treatments and future prospects. Nat. Rev. Neurol. 15, 161\u2013178. https:\/\/doi.org\/10.1038\/s41582-019-0138-8 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"45789_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","volume":"33","author":"A Kohlschutter","year":"2019","unstructured":"Kohlschutter, A., Schulz, A., Bartsch, U. & Storch, S. Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs 33, 315\u2013325. https:\/\/doi.org\/10.1007\/s40263-019-00620-8 (2019).","journal-title":"CNS Drugs"},{"key":"45789_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.mrfmmm.2005.06.019","volume":"592","author":"PA Schulte","year":"2005","unstructured":"Schulte, P. A. The use of biomarkers in surveillance, medical screening, and intervention. Mutat. Res. 592, 155\u2013163. https:\/\/doi.org\/10.1016\/j.mrfmmm.2005.06.019 (2005).","journal-title":"Mutat. Res."},{"key":"45789_CR16","volume-title":"The Detection of Biomarkers: Past, Present, and the Future Prospects","author":"SA Ozkan","year":"2021","unstructured":"Ozkan, S. A., Bakirhan, N. K. & Mollarasouli, F. The Detection of Biomarkers: Past, Present, and the Future Prospects (Elsevier Science, 2021)."},{"key":"45789_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.nhtm.2017.06.001","volume":"3","author":"DK Trivedi","year":"2017","unstructured":"Trivedi, D. K., Hollywood, K. A. & Goodacre, R. Metabolomics for the masses: The future of metabolomics in a personalized world. New Horiz. Transl. Med. 3, 294\u2013305. https:\/\/doi.org\/10.1016\/j.nhtm.2017.06.001 (2017).","journal-title":"New Horiz. Transl. Med."},{"key":"45789_CR18","doi-asserted-by":"publisher","first-page":"37245","DOI":"10.1039\/c9ra06697g","volume":"9","author":"Q Yang","year":"2019","unstructured":"Yang, Q. et al. Metabolomics biotechnology, applications, and future trends: A systematic review. RSC Adv. 9, 37245\u201337257. https:\/\/doi.org\/10.1039\/c9ra06697g (2019).","journal-title":"RSC Adv."},{"key":"45789_CR19","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1002\/jcp.24002","volume":"227","author":"CH Johnson","year":"2012","unstructured":"Johnson, C. H. & Gonzalez, F. J. Challenges and opportunities of metabolomics. J. Cell Physiol. 227, 2975\u20132981. https:\/\/doi.org\/10.1002\/jcp.24002 (2012).","journal-title":"J. Cell Physiol."},{"key":"45789_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nrm.2016.25","volume":"17","author":"CH Johnson","year":"2016","unstructured":"Johnson, C. H., Ivanisevic, J. & Siuzdak, G. Metabolomics: Beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 17, 451\u2013459. https:\/\/doi.org\/10.1038\/nrm.2016.25 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"45789_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.06.012","volume":"1866","author":"RA Kline","year":"2020","unstructured":"Kline, R. A., Wishart, T. M., Mills, K. & Heywood, W. E. Applying modern Omic technologies to the Neuronal Ceroid Lipofuscinoses. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165498. https:\/\/doi.org\/10.1016\/j.bbadis.2019.06.012 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"45789_CR22","doi-asserted-by":"publisher","first-page":"15229","DOI":"10.1038\/s41598-018-33449-0","volume":"8","author":"M Sindelar","year":"2018","unstructured":"Sindelar, M. et al. Untargeted metabolite profiling of cerebrospinal fluid uncovers biomarkers for severity of late infantile neuronal ceroid lipofuscinosis (CLN2, Batten disease). Sci. Rep. 8, 15229. https:\/\/doi.org\/10.1038\/s41598-018-33449-0 (2018).","journal-title":"Sci. Rep."},{"key":"45789_CR23","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1002\/jnr.21343","volume":"85","author":"MR Pears","year":"2007","unstructured":"Pears, M. R. et al. Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep. J. Neurosci. Res. 85, 3494\u20133504. https:\/\/doi.org\/10.1002\/jnr.21343 (2007).","journal-title":"J. Neurosci. Res."},{"key":"45789_CR24","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10858-011-9491-7","volume":"49","author":"RM Salek","year":"2011","unstructured":"Salek, R. M. et al. A metabolomic comparison of mouse models of the Neuronal Ceroid Lipofuscinoses. J. Biomol. NMR 49, 175\u2013184. https:\/\/doi.org\/10.1007\/s10858-011-9491-7 (2011).","journal-title":"J. Biomol. NMR"},{"key":"45789_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson, O. Biomarkers for neurodegenerative diseases. Nat. Med. 27, 954\u2013963. https:\/\/doi.org\/10.1038\/s41591-021-01382-x (2021).","journal-title":"Nat. Med."},{"key":"45789_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3164\/jcbn.15-39","volume":"56","author":"P Dai","year":"2015","unstructured":"Dai, P., Harada, Y. & Takamatsu, T. Highly efficient direct conversion of human fibroblasts to neuronal cells by chemical compounds. J. Clin. Biochem. Nutr. 56, 166\u2013170. https:\/\/doi.org\/10.3164\/jcbn.15-39 (2015).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"45789_CR27","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang, Z. et al. MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 49, W388\u2013W396. https:\/\/doi.org\/10.1093\/nar\/gkab382 (2021).","journal-title":"Nucleic Acids Res."},{"key":"45789_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530. https:\/\/doi.org\/10.1093\/bioinformatics\/btt703 (2014).","journal-title":"Bioinformatics"},{"key":"45789_CR29","doi-asserted-by":"publisher","first-page":"D10","DOI":"10.1093\/nar\/gkaa892","volume":"49","author":"EW Sayers","year":"2021","unstructured":"Sayers, E. W. et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 49, D10\u2013D17. https:\/\/doi.org\/10.1093\/nar\/gkaa892 (2021).","journal-title":"Nucleic Acids Res."},{"key":"45789_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5604\/12321966.1196878","volume":"23","author":"G Raszewski","year":"2016","unstructured":"Raszewski, G., Chwedorowicz, R., Chwedorowicz, A. & Gustaw Rothenberg, K. Homocysteine, antioxidant vitamins and lipids as biomarkers of neurodegeneration in Alzheimer\u2019s disease versus non-Alzheimer\u2019s dementia. Ann. Agric. Environ. Med. 23, 193\u2013196. https:\/\/doi.org\/10.5604\/12321966.1196878 (2016).","journal-title":"Ann. Agric. Environ. Med."},{"key":"45789_CR31","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.2174\/0929867324666170216113756","volume":"25","author":"R Russo","year":"2018","unstructured":"Russo, R. et al. Gut\u2013brain axis: Role of lipids in the regulation of inflammation, pain and CNS diseases. Curr. Med. Chem. 25, 3930\u20133952. https:\/\/doi.org\/10.2174\/0929867324666170216113756 (2018).","journal-title":"Curr. Med. Chem."},{"key":"45789_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105061","volume":"145","author":"F Dorninger","year":"2020","unstructured":"Dorninger, F., Forss-Petter, S., Wimmer, I. & Berger, J. Plasmalogens, platelet-activating factor and beyond\u2014Ether lipids in signaling and neurodegeneration. Neurobiol. Dis. 145, 105061. https:\/\/doi.org\/10.1016\/j.nbd.2020.105061 (2020).","journal-title":"Neurobiol. Dis."},{"key":"45789_CR33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.15698\/cst2020.07.225","volume":"4","author":"S Hernandez-Diaz","year":"2020","unstructured":"Hernandez-Diaz, S. & Soukup, S. F. The role of lipids in autophagy and its implication in neurodegeneration. Cell Stress 4, 167\u2013186. https:\/\/doi.org\/10.15698\/cst2020.07.225 (2020).","journal-title":"Cell Stress"},{"key":"45789_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41531-021-00241-3","volume":"7","author":"YE Huh","year":"2021","unstructured":"Huh, Y. E. et al. Glucosylceramide in cerebrospinal fluid of patients with GBA-associated and idiopathic Parkinson\u2019s disease enrolled in PPMI. NPJ Parkinsons Dis. 7, 102. https:\/\/doi.org\/10.1038\/s41531-021-00241-3 (2021).","journal-title":"NPJ Parkinsons Dis."},{"key":"45789_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/hmg\/ddt468","volume":"23","author":"T Farfel-Becker","year":"2014","unstructured":"Farfel-Becker, T. et al. Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration. Hum. Mol. Genet. 23, 843\u2013854. https:\/\/doi.org\/10.1093\/hmg\/ddt468 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"45789_CR36","doi-asserted-by":"publisher","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","volume":"274","author":"E Korkotian","year":"1999","unstructured":"Korkotian, E. et al. Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons. J. Biol. Chem. 274, 21673\u201321678. https:\/\/doi.org\/10.1074\/jbc.274.31.21673 (1999).","journal-title":"J. Biol. Chem."},{"key":"45789_CR37","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1074\/jbc.M509483200","volume":"281","author":"A Schulz","year":"2006","unstructured":"Schulz, A. et al. The CLN9 protein, a regulator of dihydroceramide synthase. J. Biol. Chem. 281, 2784\u20132794. https:\/\/doi.org\/10.1074\/jbc.M509483200 (2006).","journal-title":"J. Biol. Chem."},{"key":"45789_CR38","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1046\/j.1471-4159.2003.01602.x","volume":"84","author":"R Kakela","year":"2003","unstructured":"Kakela, R., Somerharju, P. & Tyynela, J. Analysis of phospholipid molecular species in brains from patients with infantile and juvenile neuronal-ceroid lipofuscinosis using liquid chromatography-electrospray ionization mass spectrometry. J. Neurochem. 84, 1051\u20131065. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01602.x (2003).","journal-title":"J. Neurochem."},{"key":"45789_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1203\/pdr.0b013e31802d8a4a","volume":"61","author":"DA Persaud-Sawin","year":"2007","unstructured":"Persaud-Sawin, D. A. et al. Neuronal ceroid lipofuscinosis: A common pathway?. Pediatr. Res. 61, 146\u2013152. https:\/\/doi.org\/10.1203\/pdr.0b013e31802d8a4a (2007).","journal-title":"Pediatr. Res."},{"key":"45789_CR40","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.1074\/jbc.RA119.008852","volume":"294","author":"C Schmidtke","year":"2019","unstructured":"Schmidtke, C. et al. Lysosomal proteome analysis reveals that CLN3-defective cells have multiple enzyme deficiencies associated with changes in intracellular trafficking. J. Biol. Chem. 294, 9592\u20139604. https:\/\/doi.org\/10.1074\/jbc.RA119.008852 (2019).","journal-title":"J. Biol. Chem."},{"key":"45789_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111840","author":"S Doccini","year":"2022","unstructured":"Doccini, S. et al. Lysosomal proteomics links disturbances in lipid homeostasis and sphingolipid metabolism to CLN5 disease. Cells https:\/\/doi.org\/10.3390\/cells11111840 (2022).","journal-title":"Cells"},{"key":"45789_CR42","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jnr.20549","volume":"81","author":"R Goswami","year":"2005","unstructured":"Goswami, R. et al. Differential regulation of ceramide in lipid-rich microdomains (rafts): Antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2. J. Neurosci. Res. 81, 208\u2013217. https:\/\/doi.org\/10.1002\/jnr.20549 (2005).","journal-title":"J. Neurosci. Res."},{"key":"45789_CR43","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1046\/j.1365-2362.2000.00757.x","volume":"30","author":"LA Granier","year":"2000","unstructured":"Granier, L. A., Langley, K., Leray, C. & Sarlieve, L. L. Phospholipid composition in late infantile neuronal ceroid lipofuscinosis. Eur. J. Clin. Investig. 30, 1011\u20131017. https:\/\/doi.org\/10.1046\/j.1365-2362.2000.00757.x (2000).","journal-title":"Eur. J. Clin. Investig."},{"key":"45789_CR44","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/jnc.14545","volume":"148","author":"ME Bosch","year":"2019","unstructured":"Bosch, M. E. & Kielian, T. Astrocytes in juvenile neuronal ceroid lipofuscinosis (CLN3) display metabolic and calcium signaling abnormalities. J. Neurochem. 148, 612\u2013624. https:\/\/doi.org\/10.1111\/jnc.14545 (2019).","journal-title":"J. Neurochem."},{"key":"45789_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells7110188","author":"S Mathavarajah","year":"2018","unstructured":"Mathavarajah, S., O\u2019Day, D. H. & Huber, R. J. Neuronal ceroid lipofuscinoses: Connecting calcium signalling through calmodulin. Cells https:\/\/doi.org\/10.3390\/cells7110188 (2018).","journal-title":"Cells"},{"key":"45789_CR46","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1021\/acs.jproteome.7b00460","volume":"16","author":"DE Sleat","year":"2017","unstructured":"Sleat, D. E. et al. Proteomic analysis of brain and cerebrospinal fluid from the three major forms of neuronal ceroid lipofuscinosis reveals potential biomarkers. J. Proteome Res. 16, 3787\u20133804. https:\/\/doi.org\/10.1021\/acs.jproteome.7b00460 (2017).","journal-title":"J. Proteome Res."},{"key":"45789_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1750-1172-8-129","volume":"8","author":"M Filocamo","year":"2013","unstructured":"Filocamo, M. et al. Telethon Network of Genetic Biobanks: A key service for diagnosis and research on rare diseases. Orphanet. J. Rare Dis. 8, 129. https:\/\/doi.org\/10.1186\/1750-1172-8-129 (2013).","journal-title":"Orphanet. J. Rare Dis."},{"key":"45789_CR48","doi-asserted-by":"publisher","first-page":"6149","DOI":"10.1038\/s41598-017-06604-2","volume":"7","author":"C Cozma","year":"2017","unstructured":"Cozma, C. et al. C26-Ceramide as highly sensitive biomarker for the diagnosis of Farber disease. Sci. Rep. 7, 6149. https:\/\/doi.org\/10.1038\/s41598-017-06604-2 (2017).","journal-title":"Sci. Rep."},{"key":"45789_CR49","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","volume":"78","author":"F Dieterle","year":"2006","unstructured":"Dieterle, F., Ross, A., Schlotterbeck, G. & Senn, H. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. Anal. Chem. 78, 4281\u20134290. https:\/\/doi.org\/10.1021\/ac051632c (2006).","journal-title":"Anal. Chem."},{"key":"45789_CR50","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart, D. S. et al. HMDB 5.0: The Human Metabolome Database for 2022. Nucleic Acids Res. 50, D622-d631. https:\/\/doi.org\/10.1093\/nar\/gkab1062 (2022).","journal-title":"Nucleic Acids Res."},{"key":"45789_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1032","author":"EW Sayers","year":"2022","unstructured":"Sayers, E. W. et al. Database resources of the National Center for Biotechnology Information in 2023. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gkac1032 (2022).","journal-title":"Nucleic Acids Res."},{"key":"45789_CR52","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1021\/ed100697w","volume":"87","author":"HE Pence","year":"2010","unstructured":"Pence, H. E. & Williams, A. ChemSpider: An online chemical information resource. J. Chem. Educ. 87, 1123\u20131124. https:\/\/doi.org\/10.1021\/ed100697w (2010).","journal-title":"J. Chem. Educ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45789-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45789-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T11:02:49Z","timestamp":1698577369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45789-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45789"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45789-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,29]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18550"}}